Research into mesenchymal stromal/stem cells (MSCs) has been particularly exciting in the
past five years. Our understanding of mechanisms of MSC-mediated tissue regeneration has …

Multipotent mesenchymal stromal cells (MSCs) have generated considerable interest in the
fields of regenerative medicine, cell therapy and immune modulation. Over the past 5 years …

Background Steroid-resistant (SR) acute graft-versus-host disease (aGVHD) lacks standard
second-line treatment. Mesenchymal stromal cells (MSCs) have potential efficacy in SR …

Refractory acute graft-versus-host disease (aGVHD) is a major cause of death after
allogeneic hematopoietic stem cell transplantation. This study evaluated the …

Recently, we demonstrated that intratracheal transplantation of human umbilical cord blood‐
derived mesenchymal stem cells (MSCs) attenuates Escherichia (E) coli‐induced acute lung …

Mesenchymal stem cells (MSCs) represent a heterogeneous population of progenitor cells
with self-renewal and multipotent differentiation potential. Aside from their regenerative role …

Osteoprogenitor cells combined with supportive biomaterials represent a promising
approach to advance the standard of care for bone grafting procedures. However, this …

Background Novel treatment options are urgently needed for multidrug-resistant (MDR) and
extensively drug-resistant (XDR) tuberculosis, which are associated with immune …

Rapid progress is occurring in understanding the mechanisms underlying mesenchymal
stromal cell (MSC)-based cell therapies (MSCT). However, the results of clinical trials, while …

Acute myocardial infarction (AMI) is the leading cause of cardiovascular death and remains
the most common cause of heart failure. Reopening of the occluded artery, ie, reperfusion, is …